On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...
Morning Overview on MSN
The government just greenlit a daraxonrasib expanded-access program for pancreatic-cancer patients with the KRAS G12C mutation — opening the new targe…
For the roughly 1 to 2 percent of pancreatic-cancer patients whose tumors carry a specific genetic glitch called KRAS G12C, ...
Why do pharmaceutical companies charge exorbitant rates for their products but then give them away for free or virtually no cost to most patients, regardless of income, through patient assistance ...
The 340B Drug Pricing Program was created in 1992 to increase access to hospital outpatient medications for low‐income and uninsured patients by allowing covered entities that serve these patients to ...
On a recent November evening, Angie Phoenix waited at a pharmacy here in Colorado’s second-largest city to pick up prescription drugs to treat her high blood pressure and arm seizures. But this ...
As President Donald Trump entered office this week, one of his first major policy moves on healthcare was to roll back a Biden administration executive order aimed at lowering prescription drug prices ...
Warning: This graphic requires JavaScript. Please enable JavaScript for the best experience. EVANSVILLE, Ind. — Lavender Timmons popped the trunk of her weather ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results